Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population

The Reagan-Udall Foundation for the FDA, in cooperation with the Food and Drug Administration, will convene a hybrid public meeting to gather input on the clinical use and safety concerns associated with orally ingestible unapproved prescription drug products containing fluoride for use in children.

Food Safety Magazine: 2025 Food Safety Summit Town Hall Offers Candid Dialogue with Federal Regulators, Advisors

Mr. Diamantas first shared some background with attendees on where FDA is headed and the agency's vision for modernization. He spoke about the Reagan-Udall Foundation's December 2022 report of its independent review of FDA's Human Foods Program (HFP), which uncovered logistical and functional challenges. As a result of this review, the reorganization of the HFP was implemented in October 2024.
Coverage
Subscribe to